Ahmed Eltelbany, MD, MPH

Cleveland Clinic

Poster(s):

• A0015 - Immune Checkpoint-Inhibitors Are Associated With a Higher Risk of Cholangitis: A Nationwide Population-Wide Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0194 - Hypogonadism and Testosterone Replacement Therapy Are Associated with a Higher Risk of GERD in Males: A National Cohort Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0383 - Impact of Biologics Therapy on the Prevalence of Pregnancy Complications Among Women With Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0384 - Impact of Biologics Therapy on the Prevalence of Parkinson’s Disease Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0385 - Patients With Neuro-Developmental Disorders Are Associated With a Higher Risk of Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0386 - Impact of Biologics Therapy on the Prevalence of Erectile Dysfunction Among Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0387 - Impact of Obesity on Outcomes of Patients With Inflammatory Bowel Disease: A National Inpatient Sample Analysis
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0575 - A Rare Case of Antiphospholipid Syndrome Presenting With Variceal Bleeding and Ascites Secondary to Portal Vein Thrombosis Without Liver Cirrhosis
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET

• A0693 - Immune Checkpoint-Inhibitors Are Associated With a Higher Risk of Gastritis: A Nationwide Population-Wide Study
  Sunday, October 23, 2022

  5:00 PM – 7:00 PM ET